|
시장보고서
상품코드
1961012
기관내 튜브 시장 인사이트, 경쟁 구도 및 시장 예측(-2034년)Endotracheal Tubes Market Insights, Competitive Landscape, and Market Forecast - 2034 |
||||||
DelveInsight
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.
가격
※ 부가세 별도
한글목차
영문목차
기관내 튜브 시장 : 요약
- 세계의 기관내 튜브 시장 규모는 2025년 20억 2,176만 달러에서 2034년에는 36억 9,185만 달러로 증가하며, 견고하고 지속적인 성장이 전망되고 있습니다.
- 세계 기관내 튜브 시장 규모는 2026-2034년의 예측 기간 중 연평균 6.97%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.
- 기관내 튜브 시장은 주로 만성 호흡기 질환 및 암 환자 증가, 수술 및 중환자실(ICU) 입원 건수 증가, 신생아 중환자실(NICU) 및 소아 중환자실(PICU) 입원 건수 증가에 의해 주도되고 있습니다. 이러한 요인들로 인해 모든 연령대에서 신뢰할 수 있는 기도 관리에 대한 수요가 크게 증가하면서 기관내관(ETT) 시장의 견고한 성장을 가속하고 있습니다. 만성 호흡기 질환과 암은 종종 호흡 부전이나 복잡한 외과적 개입을 유발하고 장기적인 삽관이나 인공호흡을 필요로 합니다. 한편, 대수술 및 중환자실 입원 건수 증가는 수술실과 중환자실에서 기관내 튜브의 일상적인 사용을 더욱 증가시키고 있습니다. 동시에 조산, 저체중아, 선천성 질환으로 인한 NICU 및 PICU 입원이 증가함에 따라 신생아 및 소아 전용 기관내 튜브에 대한 수요가 증가하고 있습니다. 이러한 요인들이 복합적으로 작용하여 수술 건수와 환자 1인당 기관내 튜브 사용량이 증가하고 있으며, 급성기, 수술 및 중환자 치료 환경에서 기관내 튜브의 필수적인 역할을 강화하여 전체 시장 확대를 가속화하고 있습니다.
- 기관내 튜브 시장의 주요 기업으로는 Medtronic, Teleflex Incorporated, ConvaTec, Inc., Vygon, N8 Medical, LLC, Novo Klinik-Service GmbH, Intersurgical Ltd., AirLife, Angiplast Pvt Ltd., Guangzhou Orcl Medical Co.,Ltd., Sumi, Van Oostveen Medical B.V., DEAS S.R.L, ICU Medical Inc., Sterimed Group, Respicare., Hangzhou BEVER Medical Devices Co., Ltd., Bryan Medical, Flexicare(Group) Limited, Viggo Medical Devices 등을 들 수 있습니다.
- 북미는 만성 호흡기 질환 및 암 환자 증가, 수술 건수 증가, 외상 및 사고 건수 증가로 인해 기관내 튜브 시장을 촉진할 것으로 예측됩니다.
- 기관내 튜브 시장의 제품 유형별 부문에서 강화 유형은 2025년에 가장 큰 시장 점유율을 차지할 것으로 예측됩니다.
세계의 기관내 튜브(Endotracheal Tube) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규제 환경, 시장 규모 추이 및 예측, 각종 부문별/지역별/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
자주 묻는 질문
목차
제1장 기관내 튜브 시장 : 리포트의 개요
제2장 기관내 튜브 시장 : 개요
제3장 기관내 튜브 시장 : 주요 요인 분석
제4장 영향 분석
제5장 규제 분석
제6장 기관내 튜브 시장 : Porter's Five Forces 분석
제7장 기관내 튜브 시장 : 시장 평가
제8장 경쟁 구도
제9장 스타트업 자금조달과 투자 동향
제10장 기관내 튜브 시장 : 기업·제품 개요
제11장 KOL의 견해
제12장 프로젝트 어프로치
제13장 DelveInsight 소개
제14장 면책사항·문의
KSA 26.03.23Endotracheal Tubes Market Summary
- The global endotracheal tubes market is expected to increase from USD 2,021.76 million in 2025 to USD 3,691.85 million by 2034, reflecting strong and sustained growth.
- The global endotracheal tubes market is growing at a CAGR of 6.97% during the forecast period from 2026 to 2034.
- The market of endotracheal tubes is being primarily driven by the increasing prevalence of chronic respiratory disorders and cancer cases, the growing number of surgical procedures and ICU admissions, and the rising NICU and PICU admissions are collectively driving strong growth in the endotracheal tubes (ETTs) market by substantially increasing the demand for reliable airway management across all age groups. Chronic respiratory diseases and cancer often lead to respiratory failure or complex surgical interventions, requiring prolonged intubation and mechanical ventilation, while the rising volume of major surgeries and critical care admissions further elevates routine ETT usage in operating rooms and ICUs. At the same time, higher NICU and PICU admissions driven by preterm births, low birth weight, and congenital disorders are expanding demand for specialized neonatal and pediatric ETTs. Together, these factors are increasing both procedure volumes and per-patient ETT utilization, reinforcing the essential role of endotracheal tubes in acute, surgical, and critical care settings and accelerating overall market expansion.
- The leading companies operating in the endotracheal tubes market include Medtronic, Teleflex Incorporated, ConvaTec, Inc., Vygon, N8 Medical, LLC, Novo Klinik-Service GmbH, Intersurgical Ltd., AirLife, Angiplast Pvt Ltd., Guangzhou Orcl Medical Co.,Ltd., Sumi, Van Oostveen Medical B.V., DEAS S.R.L, ICU Medical Inc., Sterimed Group, Respicare., Hangzhou BEVER Medical Devices Co., Ltd., Bryan Medical, Flexicare (Group) Limited, Viggo Medical Devices, and others.
- North America is expected to dominate the overall endotracheal tubes market due to the growing prevalence of chronic respiratory disorders and cancer cases, increased surgical procedures, and rising number of trauma and accident cases have boosted the overall market across the region.
- In the product type segment of the endotracheal tubes market, the reinforced category is estimated to account for the largest market share in 2025.
Key takeaways from the Endotracheal Tubes market report study
- Market size analysis for the current endotracheal tubes market size (2025), and market forecast for 8 years (2026 to 2034)
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
- Key companies dominating the endotracheal tubes market.
- Various opportunities available for the other competitors in the endotracheal tubes market space.
- What are the top-performing segments in 2025? How these segments will perform in 2034?
- Which are the top-performing regions and countries in the current endotracheal tubes market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for the endotracheal tubes market growth in the future?
Frequently Asked Questions for the Endotracheal Tubes Market
1. What is the growth rate of the endotracheal tubes market?
- The endotracheal tubes market is estimated to grow at a CAGR of 6.97% during the forecast period from 2026 to 2034.
2. What is the market for endotracheal tubes?
- The global endotracheal tubes market is expected to increase from USD 2,021.76 million in 2025 to USD 3,691.85 million by 2034.
3. Which region has the highest share in the endotracheal tubes market?
- North America is expected to account for the highest proportion of 35.69% of the endotracheal tubes market in 2025, out of all regions. This domination is due to the growing prevalence of chronic respiratory disorders and cancer cases, increased surgical procedures, and rising number of trauma and accident cases have boosted the overall market across the region.
4. What are the drivers for the Endotracheal Tubes market?
- The market of endotracheal tubes is being primarily driven by the increasing prevalence of chronic respiratory disorders and cancer cases, the growing number of surgical procedures and ICU admissions, and the rising NICU and PICU admissions are collectively driving strong growth in the endotracheal tubes (ETTs) market by substantially increasing the demand for reliable airway management across all age groups. Chronic respiratory diseases and cancer often lead to respiratory failure or complex surgical interventions, requiring prolonged intubation and mechanical ventilation, while the rising volume of major surgeries and critical care admissions further elevates routine ETT usage in operating rooms and ICUs. At the same time, higher NICU and PICU admissions driven by preterm births, low birth weight, and congenital disorders are expanding demand for specialized neonatal and pediatric ETTs. Together, these factors are increasing both procedure volumes and per-patient ETT utilization, reinforcing the essential role of endotracheal tubes in acute, surgical, and critical care settings and accelerating overall market expansion.
5. Who are the key players operating in the endotracheal tubes market?
- Some of the key market players operating in the endotracheal tubes market include Medtronic, Teleflex Incorporated, ConvaTec, Inc., Vygon, N8 Medical, LLC, Novo Klinik-Service GmbH, Intersurgical Ltd., AirLife, Angiplast Pvt Ltd., Guangzhou Orcl Medical Co.,Ltd., Sumi, Van Oostveen Medical B.V., DEAS S.R.L, ICU Medical Inc., Sterimed Group, Respicare., Hangzhou BEVER Medical Devices Co., Ltd., Bryan Medical, Flexicare (Group) Limited, Viggo Medical Devices, and others.
Table of Contents
1. Endotracheal Tubes Market Report Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.3 Market Assumption
2. Endotracheal Tubes Market Executive Summary
- 2.1 Market at Glance
3. Endotracheal Tubes Market Key Factors Analysis
- 3.1 Endotracheal Tubes Market Drivers
- 3.1.1 Increasing prevalence of chronic respiratory disorders and cancer cases
- 3.1.2 Increasing number of surgical procedures and ICU admission
- 3.1.3 Rising NICU and PICU admissions
- 3.2 Endotracheal Tubes Market Restraints and Challenges
- 3.2.1 Risk of complication during insertion of endotracheal tubes
- 3.2.2 Increased number of product recalls due to safety
- 3.3 Endotracheal Tubes Market Opportunity
- 3.3.1 Development of safer and technologically advanced endotracheal tubes
4. Impact Analysis
- 4.1 AI-Powered Innovations and Applications
- 4.2 U.S. Tariff Impact Analysis
5. Regulatory Analysis
- 5.1 The United States
- 5.2 Europe
- 5.3 Japan
- 5.4 China
6. Endotracheal Tubes Market Porter's Five Forces Analysis
- 6.1 Bargaining Power of Suppliers
- 6.2 Bargaining Power of Consumers
- 6.3 Threat of New Entrants
- 6.4 Threat of Substitutes
- 6.5 Competitive Rivalry
7. Endotracheal Tubes Market Assessment
- 7.1 By Product Type
- 7.1.1 Standard
- 7.1.2 Reinforced
- 7.1.3 Coated
- 7.1.4 Others
- 7.2 By Cuff Type
- 7.2.1 Cuffed
- 7.2.2 Uncuffed/Cuffless
- 7.3 By Intubation Route
- 7.3.1 Oral
- 7.3.2 Nasal
- 7.4 By Age Group
- 7.4.1 Adults
- 7.4.2 Pediatrics
- 7.5 By End-Users
- 7.5.1 Hospitals
- 7.5.2 Ambulatory Surgical Centers
- 7.5.3 Others
- 7.6 By Geography
- 7.6.1 North America
- 7.6.1.1 United States Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.1.2 Canada Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.1.3 Mexico Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.2 Europe
- 7.6.2.1 France Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.2.2 Germany Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.2.3 United Kingdom Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.2.4 Italy Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.2.5 Spain Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.2.6 Rest of Europe Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.3 Asia-Pacific
- 7.6.3.1 China Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.3.2 Japan Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.3.3 India Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.3.4 Australia Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.3.5 South Korea Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.3.6 Rest of Asia-Pacific Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.4 Rest of the World (RoW)
- 7.6.4.1 Middle East Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.4.2 Africa Endotracheal Tubes Market Size in USD million (2023-2034)
- 7.6.4.3 South America Endotracheal Tubes Market Size In USD Million (2023-2034)
- 7.6.1 North America
8. Competitive Landscape
9. Startup Funding & Investment Trends
10. Endotracheal Tubes Market Company and Product Profiles
- 10.1 Medtronic
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Product Listing
- 10.1.5 Entropy
- 10.2 Teleflex Incorporated
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Listing
- 10.2.5 Entropy
- 10.3 ConvaTec, Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Listing
- 10.3.5 Entropy
- 10.4 Vygon
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Listing
- 10.4.5 Entropy
- 10.5 N8 Medical, LLC
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Listing
- 10.5.5 Entropy
- 10.6 Novo Klinik-Service GmbH
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Listing
- 10.6.5 Entropy
- 10.7 Intersurgical Ltd.
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Listing
- 10.7.5 Entropy
- 10.8 AirLife
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Listing
- 10.8.5 Entropy
- 10.9 Angiplast Pvt Ltd.
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Listing
- 10.9.5 Entropy
- 10.10 Guangzhou Orcl Medical Co.,Ltd.
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Listing
- 10.10.5 Entropy
- 10.11 Sumi
- 10.11.1 Company Overview
- 10.11.2 Company Snapshot
- 10.11.3 Financial Overview
- 10.11.4 Product Listing
- 10.11.5 Entropy
- 10.12 Van Oostveen Medical B.V.
- 10.12.1 Company Overview
- 10.12.2 Company Snapshot
- 10.12.3 Financial Overview
- 10.12.4 Product Listing
- 10.12.5 Entropy
- 10.13 DEAS S.R.L
- 10.13.1 Company Overview
- 10.13.2 Company Snapshot
- 10.13.3 Financial Overview
- 10.13.4 Product Listing
- 10.13.5 Entropy
- 10.14 ICU Medical Inc.
- 10.14.1 Company Overview
- 10.14.2 Company Snapshot
- 10.14.3 Financial Overview
- 10.14.4 Product Listing
- 10.14.5 Entropy
- 10.15 Sterimed Group
- 10.15.1 Company Overview
- 10.15.2 Company Snapshot
- 10.15.3 Financial Overview
- 10.15.4 Product Listing
- 10.15.5 Entropy
- 10.16 Respicare.
- 10.16.1 Company Overview
- 10.16.2 Company Snapshot
- 10.16.3 Financial Overview
- 10.16.4 Product Listing
- 10.16.5 Entropy
- 10.17 Hangzhou BEVER Medical Devices Co., Ltd.
- 10.17.1 Company Overview
- 10.17.2 Company Snapshot
- 10.17.3 Financial Overview
- 10.17.4 Product Listing
- 10.17.5 Entropy
- 10.18 Bryan Medical
- 10.18.1 Company Overview
- 10.18.2 Company Snapshot
- 10.18.3 Financial Overview
- 10.18.4 Product Listing
- 10.18.5 Entropy
- 10.19 Flexicare (Group) Limited
- 10.19.1 Company Overview
- 10.19.2 Company Snapshot
- 10.19.3 Financial Overview
- 10.19.4 Product Listing
- 10.19.5 Entropy
- 10.20 Viggo Medical Devices
- 10.20.1 Company Overview
- 10.20.2 Company Snapshot
- 10.20.3 Financial Overview
- 10.20.4 Product Listing
- 10.20.5 Entropy
